You are here

B. Brett Finlay


Department of Biochemistry and Molecular Biology, Department of Microbiology and Immuology, Michael Smith Laboratories

Dr. Finlay’s research interests focus on host-microbe interactions at the molecular level. By combining cell biology with microbiology, he has been at the forefront of the field called Cellular Microbiology. His laboratory studies several pathogenic bacteria, including Salmonella and pathogenic E. coli, and more recently microbiota. He has won several prestigious awards including the E.W.R. Steacie Prize, five Howard Hughes International Research Scholar Awards, BC Biotech Innovation Award, the Michael Smith Health Research Prize, the prestigious Canadian Killam Health Sciences Prize, the Queen Elizabeth II Diamond Jubilee Medal, amongst others. He is a cofounder of Inimex Pharmaceuticals, Inc. and Microbiome Insights, scientific cofounder of Vedanta Pharmaceuticals and CommenSe, Director of the SARS Accelerated Vaccine Initiative, and Founding Director and Senior Fellow of CIFAR’s Microbes and Humans. He is also the co-author of the books Let Them Eat Dirt and The Whole Body Microbiome.